Managing Jaw Clenching from Adderall: Alternative ADHD Medications
For an adult patient experiencing jaw clenching from Adderall, switching to a non-stimulant medication such as atomoxetine (Strattera) is the recommended approach. 1
First-Line Alternative Options
Non-Stimulant Medications
Atomoxetine (Strattera)
- Starting dose: 0.5 mg/kg/day
- Target dose: 1.2 mg/kg/day
- Benefits: Does not worsen tics and has lower abuse potential 1
- No risk of jaw clenching as it works through a different mechanism (selective norepinephrine reuptake inhibitor)
Guanfacine (Intuniv)
- Dosing: 0.1 mg/kg once daily
- Alpha-2 adrenergic receptor agonist that enhances noradrenergic neurotransmission in the prefrontal cortex 1
- Side effects include nausea, fatigue, and somnolence, but no jaw clenching
Alternative Stimulant Options
If non-stimulants are not effective and you need to stay with stimulants:
- Consider a different stimulant formulation
- Lisdexamfetamine (Vyvanse) may have different side effect profile than Adderall
- Methylphenidate-based medications (Concerta, Ritalin) work through a slightly different mechanism than amphetamine-based medications like Adderall 2
Decision Algorithm
First try: Atomoxetine (Strattera)
- Most evidence-supported non-stimulant for ADHD
- Approximately 50% of non-responders to methylphenidate will respond to atomoxetine therapy 3
If atomoxetine is ineffective or poorly tolerated: Try Guanfacine (Intuniv)
- Particularly useful if the patient also has anxiety symptoms 1
If non-stimulants fail: Consider a methylphenidate-based stimulant
- Different mechanism than amphetamine-based medications (like Adderall)
- May not cause the same jaw clenching side effect
Switching Process
When switching from Adderall to atomoxetine:
- Initiate atomoxetine with a schedule of dose increases while cross-tapering with Adderall
- Use a slow titration schedule with divided doses to minimize adverse events
- Atomoxetine and Adderall can be co-administered during the switching period with monitoring of blood pressure and heart rate 3
- Allow for a trial period of at least 6-8 weeks to evaluate the overall tolerability and efficacy of atomoxetine
Important Considerations
- Bupropion is another potential option but should be used with caution due to its activating properties which may worsen anxiety symptoms 1
- For patients with comorbid substance use disorders, non-stimulants are preferred due to lower abuse potential 1
- Regular monitoring of blood pressure, heart rate, and other side effects is recommended at each follow-up visit 1
- Schedule follow-up within 2-4 weeks after medication initiation to assess response and side effects
Caveat
Jaw clenching (bruxism) is a recognized side effect of amphetamine-based medications like Adderall 2. This side effect is less common with non-stimulant medications, making them a suitable alternative for patients experiencing this specific adverse effect.